Journal of Comparative Effectiveness Research

A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study

By Philippe Debonnaire, Peter-Paul M. Zwetsloot, Roman Pfister, Tomás Ripoll-Vera

Study in peopleInterventions

The paper

Philippe Debonnaire, Peter-Paul M. Zwetsloot, Roman Pfister, Tomás Ripoll-Vera

AZ Sint-Jan; Hospital Son Llatzer

Journal of Comparative Effectiveness Research, 14 Sep 2026

doi.org/10.57264/cer-2026-0114 PubMed 42734113

The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease